Peptides DB
Research-centric peptide and protocol reference hub

Glow Stack (BPC-157 + TB-500 + GHK-Cu) vs SS-31

Updated July 28, 2026 · Reviewed by the PeptidesDB Editorial team

Glow Stack (BPC-157 + TB-500 + GHK-Cu): Research use — not FDA-approvedSS-31: Research use — not FDA-approved

A data-driven comparison of Glow Stack (BPC-157 + TB-500 + GHK-Cu) and SS-31 (also searched as SS-31 vs Glow Stack (BPC-157 + TB-500 + GHK-Cu)) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.

Verdict

Glow Stack (BPC-157 + TB-500 + GHK-Cu) centers on healing, while SS-31 leans toward inflammation. On indexed research, SS-31 is ahead (Glow Stack (BPC-157 + TB-500 + GHK-Cu): 1 study, Preclinical; SS-31: 19, Human evidence). Choose by goal — and read the primary studies. This is research information, not medical advice.

Key takeaways

  • Glow Stack (BPC-157 + TB-500 + GHK-Cu) is strongest for healing; SS-31 for inflammation.
  • Evidence: Glow Stack (BPC-157 + TB-500 + GHK-Cu) Preclinical (1 study) vs SS-31 Human evidence (19).
  • Both are research-use compounds — not FDA-approved.

Effect profiles, overlaid

Glow Stack (BPC-157 + TB-500 + GHK-Cu): Healing 4.0, Muscle 2.0, Metabolic 1.0, Neuro 2.0, Sleep 1.0, Immune 4.0, Skin 3.0 — SS-31: Healing 3.0, Muscle 2.0, Metabolic 4.0, Neuro 3.0, Sleep 1.0, Immune 4.0, Skin 0.0Healing & recovery — 4.0 / 5 · Glow Stack (BPC-157 + TB-500 + GHK-Cu)Muscle & body comp — 2.0 / 5 · Glow Stack (BPC-157 + TB-500 + GHK-Cu)Metabolic & appetite — 1.0 / 5 · Glow Stack (BPC-157 + TB-500 + GHK-Cu)Neuro & mood — 2.0 / 5 · Glow Stack (BPC-157 + TB-500 + GHK-Cu)Sleep & circadian — 1.0 / 5 · Glow Stack (BPC-157 + TB-500 + GHK-Cu)Inflammation & immune — 4.0 / 5 · Glow Stack (BPC-157 + TB-500 + GHK-Cu)Skin & aesthetics — 3.0 / 5 · Glow Stack (BPC-157 + TB-500 + GHK-Cu)Healing & recovery — 3.0 / 5 · SS-31Muscle & body comp — 2.0 / 5 · SS-31Metabolic & appetite — 4.0 / 5 · SS-31Neuro & mood — 3.0 / 5 · SS-31Sleep & circadian — 1.0 / 5 · SS-31Inflammation & immune — 4.0 / 5 · SS-31HealingMuscleMetabolicNeuroSleepImmuneSkin
Glow Stack (BPC-157 + TB-500 + GHK-Cu)SS-31

At a glance

Healing | Tissue repair and inflammation modulation

Strongest: HealingStudies: 1Level: Limited Research
SS-31Human evidence

Mitochondrial-Targeted Peptide | Cardiolipin Protector

Strongest: InflammationStudies: 19Level: Well Studied

Glow Stack (BPC-157 + TB-500 + GHK-Cu) vs SS-31: side-by-side

MetricGlow Stack (BPC-157 + TB-500 + GHK-Cu)SS-31
ClassHealingLongevity
Regulatory statusResearch use onlyResearch use only
Evidence gradePreclinicalHuman evidence
Studies indexed119
Research levelLimited ResearchWell Studied
Strongest effectHealing & recoveryInflammation & immune
Healing & recovery4.03.0
Muscle & body comp2.02.0
Metabolic & appetite1.04.0
Neuro & mood2.03.0
Sleep & circadian1.01.0
Inflammation & immune4.04.0
Skin & aesthetics3.00.0

▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).

Mechanism & pharmacokinetics

PropertyGlow Stack (BPC-157 + TB-500 + GHK-Cu)SS-31
MechanismBody-protective compound (pentadecapeptide); cytoprotective, pro-angiogenic signalingTargets inner mitochondrial membrane to enhance function and reduce ROS
RouteSubcutaneous / oral (research use)Subcutaneous injection

Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.

What is Glow Stack (BPC-157 + TB-500 + GHK-Cu)?

### Summary The Glow Stack, comprising BPC-157, TB-500, and GHK-Cu, is a combination of peptides that has garnered interest for its potential roles in tissue repair, inflammation modulation, and skin health. Research into these peptides suggests various biological activities, though comprehensive clinical data on their combined effects is still limited.

Full Glow Stack (BPC-157 + TB-500 + GHK-Cu) profile, mechanism & studies →

What is SS-31?

### Summary SS-31, also known as Elamipretide, is a peptide that has garnered attention for its potential role in mitochondrial protection and its implications in various health conditions, particularly those involving oxidative stress and mitochondrial dysfunction.

Full SS-31 profile, mechanism & studies →

Which is better for your goal?

GoalBetter fitWhy
HealingGlow Stack (BPC-157 + TB-500 + GHK-Cu)4.0/5 effect signal
MuscleEvenBoth ~2.0/5
MetabolicSS-314.0/5 effect signal
NeuroSS-313.0/5 effect signal
SleepEvenBoth ~1.0/5
InflammationEvenBoth ~4.0/5
SkinGlow Stack (BPC-157 + TB-500 + GHK-Cu)3.0/5 effect signal

Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.

Can you stack Glow Stack (BPC-157 + TB-500 + GHK-Cu) and SS-31?

People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.

Glow Stack (BPC-157 + TB-500 + GHK-Cu) vs SS-31: side effects

Glow Stack (BPC-157 + TB-500 + GHK-Cu)

No community-reported effects logged yet.

SS-31

No community-reported effects logged yet.

Anonymous community reports (count = number of reports), not clinical incidence rates.

What the research says

Glow Stack (BPC-157 + TB-500 + GHK-Cu) has 1 approved study indexed (Preclinical), and SS-31 has 19 (Human evidence). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.

Frequently asked questions

Is Glow Stack (BPC-157 + TB-500 + GHK-Cu) or SS-31 better?

It depends on your goal. Glow Stack (BPC-157 + TB-500 + GHK-Cu) is strongest for healing; SS-31 for inflammation. SS-31 has more indexed studies (19). See the goal-by-goal breakdown above.

Is Glow Stack (BPC-157 + TB-500 + GHK-Cu) or SS-31 better for weight loss?

SS-31 shows the stronger metabolic & appetite profile (4.0/5) in the AI-assigned effect profile — though weight-loss outcomes depend on the individual and the evidence base.

Is Glow Stack (BPC-157 + TB-500 + GHK-Cu) or SS-31 better for muscle?

Both land close on the muscle & body-composition axis.

Which has more research, Glow Stack (BPC-157 + TB-500 + GHK-Cu) or SS-31?

Glow Stack (BPC-157 + TB-500 + GHK-Cu) has 1 approved study indexed (Preclinical); SS-31 has 19 (Human evidence). Higher counts mean more to read, not proven superiority.

Can you stack Glow Stack (BPC-157 + TB-500 + GHK-Cu) and SS-31?

Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.

What are the side effects of Glow Stack (BPC-157 + TB-500 + GHK-Cu) vs SS-31?

Glow Stack (BPC-157 + TB-500 + GHK-Cu): no community-reported effects logged yet. SS-31: none logged yet. These are anonymous reports, not incidence rates — see each profile.

Is Glow Stack (BPC-157 + TB-500 + GHK-Cu) or SS-31 FDA-approved?

Glow Stack (BPC-157 + TB-500 + GHK-Cu) is a research-use compound and is not FDA-approved. SS-31 is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.

Is SS-31 better than Glow Stack (BPC-157 + TB-500 + GHK-Cu)?

For inflammation, SS-31 has the edge; for healing, Glow Stack (BPC-157 + TB-500 + GHK-Cu) does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.

Comparing related peptides

Regulatory & legal status

Glow Stack (BPC-157 + TB-500 + GHK-Cu) and SS-31 are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed July 28, 2026.